Arizona Pharmacy Flash
Feb. 12, 2013

Hoping to ease shortage, FDA fast-tracks generic form of cancer drug
HealthDay News via U.S. News & World Report
Seeking to ease potentially dangerous shortages of a key cancer drug, the Food and Drug Administration recently announced it had fast-tracked the approval of the first generic form of one such medication, Doxil. "The agency is committed to doing everything we can to address drug shortages so that patients can get the medicines they need when they need them," Capt. Valerie Jensen, director of the Drug Shortage Staff at the FDA's Center for Drug Evaluation and Research, said in an agency news release. "For the past year, the FDA has been working to ensure that supplies of [doxorubicin] were not interrupted."More

Pharmacist and Patient-Centered Diabetes Care Certificate Training Program
Date: April 5
The Pharmacist and Patient-Centered Diabetes Care Certificate Training Program is an innovative and intensive certificate program that focuses on the pharmacist's role in the area of diabetes management. The program, which emphasizes a healthcare team approach, seeks to foster the implementation of pharmaceutical care interventions that will promote disease self-management.More

Not an AzPA member? Join today
Not an AzPA member? Join the only statewide association representing all pharmacy professionals in all pharmacy practice settings. With over 1,500 members, we are a leading association of pharmacists spreading the news and events of our industry.More

Pharmacists a-Twitter: Is it time to ride this social media wave?
Pharmacy Practice News
Twitter: It's not just for Ashton Kutcher and the Kardashians. Healthcare providers, including pharmacists, are increasingly using Twitter professionally. Rachelle "Shelly" Spiro, a Las Vegas-based pharmacist, was one of more than 500 attendees at American Society of Health-System Pharmacists Midyear who were tweeting items that they found intriguing or useful from the meeting, most of them using the hashtag #ashpmidyear.More

Long-term care pharmacy groups propose changes to make short-cycle dispensing more efficient, cost-effective
McKnight's Long-Term Care News
Long-term care pharmacies are struggling with an Affordable Care Act provision related to short-cycle dispensing of brand name oral solid drugs, according to a recent letter from the Long Term Care Pharmacy Alliance and the National Community Pharmacists Association. Policymakers must quickly come up with a better definition of "brand name drugs," the two trade associations urged in their letter to the Centers for Medicare & Medicaid Services. More

Why people love working for big pharmaceutical companies
Business Insider
When Elizabeth Lim decided that she wanted to become a pharmacist, she was aware that there was some negative public perception about the industry. However, Lim said that the negative image surrounding pharmacy representatives has dramatically improved in recent years. For example, the industry came to a general consensus that it's inappropriate for reps to give away promotional items as they're advertising new drugs. More

Pharmacy students learn how to protect from robberies
A pharmacy student who was robbed on the job in Bangor, Maine, started a program to help prepare other pharmacy students for robberies.More

Want to be published?
In an effort to enhance the overall content of Pharmacy Flash, we'd like to include peer-written articles in future editions. As a member of the pharmaceutical industry, your knowledge lends itself to unprecedented expertise. And we're hoping you'll share this expertise with your peers through well-written commentary. Because of the digital format, there's no word or graphical limit and our group of talented editors can help with final edits. If you're interested in participating, please contact Colby Horton to discuss logistics and payment.More

Calcium supplements linked to mortality risk in men, not women
The debate over the safety of calcium supplements has been muddied with the publication of a new analysis showing that a high intake of supplemental calcium increases the risk of cardiovascular disease death in men but not in women. Compared with individuals who took no calcium, men who consumed 1000 mg or more of supplemental calcium per day had a significant 20 percent increased risk of CVD death, a risk that was driven by a significant 19 percent increased risk of heart disease death.More

Topiramate and language impairment: Finding the cause
Pharmacy Times
The selection of an anti-epileptic drug for patients with epilepsy or neuropathic pain depends on numerous factors. In addition to considering the patient's seizure profile, age, organ function and concurrent drug therapy, prescribers and patients must weigh concerns about a given medication's side effect profile. One notable side effect that has been reported by healthy volunteers and epilepsy patients taking the AED topiramate has been language impairment, specifically difficulties with word finding.More

Harvard researcher: Pharmacy the most gender-equal profession
According to research conducted by a Harvard economist, a pharmacy profession is the most equal job for men and women. The profession offers a six-figure salary in a fast-growing field. More

Potential Alzheimer's vaccine shows early promise
Pharmacy Times
Researchers from Laval University, CHU de Quebec and GlaxoSmithKline have reported progress in their quest for a vaccine to prevent Alzheimer's disease. Using a mouse model of AD, they have successfully stimulated the brain's natural defense mechanisms with monophosphoryl lipid A, a vaccine adjuvant that has been used extensively by GSK.More

Pomalidomide approved for multiple myeloma
American Society of Health-System Pharmacists
The FDA on Feb. 8 announced the approval of pomalidomide, a thalidomide analogue, as a treatment for multiple myeloma that has progressed after previous therapies. Labeling for pomalidomide states that the drug is indicated in patients who have undergone at least two cycles of therapy for multiple myeloma, including treatment with lenalidomide and bortezomib, but whose disease has progressed within 60 days after finishing the most recent treatment cycle. More

NSAIDs linked to acute kidney injury in dehydrated kids
Commonly used nonsteroidal anti-inflammatory drugs can lead to acute kidney injury in pediatric patients, particularly those suffering from dehydration, suggest the results of a retrospective study published online in the Journal of Pediatrics.More